Search News Archives
Follow us on
Conferences | Events

Media Partners

 

BioFocus extends collaboration with Usher III Initiative

BiofocusBioFocus has announced that it has expanded a collaboration with the Usher III Initiative, Inc., a non-profit organization focused on developing treatments for Usher syndrome type III, a rare genetic disorder that causes the loss of hearing and vision. 

BioFocus and the Usher III Initiative began their collaboration in July 2010 with BioFocus performing an integrated drug discovery program encompassing medicinal chemistry, ADME and biological sciences, aiming at a small-molecule therapy for Usher syndrome type III.  Under the terms of the extended agreement, BioFocus will further advance the project with the objective of delivering a pre-clinical candidate. 

"The extension of this collaboration is testament to the quality of the scientific input that BioFocus offers its clients," said Dr Chris Newton, Senior Vice President Galapagos Services.  "The quality of the science at BioFocus enables it to sustain its position as a premier provider in drug discovery services."

"We are pleased with the progress BioFocus has made thus far on discovering potential therapies for Usher syndrome.  BioFocus' approach fits very well with our aim of getting therapies into the clinic quickly and efficiently," said Dr. David Saperstein, Scientific Director, Usher III Initiative, Inc. 

About Usher III Initiative, Inc.

The Usher III Initiative, Inc. is a non-profit organization dedicated to developing cures for blindness associated with Usher syndrome type III.  The Initiative funds research at universities and contract research organizations in the United States and Europe.  More info is available at:  www.usheriii.org

About BioFocus

BioFocus delivers drug discovery solutions through a comprehensive platform run by dedicated teams with a track record in gene-to-clinical candidate discovery.  BioFocus' offering includes target discovery in human primary cells, focused as well as diverse compound libraries, in vitro and cell-based screening, structural biology, medicinal chemistry and ADME/PK services, supported by unique chemogenomic and informatics tools.  As a service division of Galapagos, BioFocus has over 210 employees with research facilities in three countries.  More info at: www.biofocus.com 


If you have not logged into the website then please enter your details below.



 


Popular this Month

 

Win a PIPETBOY from the new Integra summer collection!

 

Great Savings off Selected GC Columns

 

CytoSMART raises 5.2 million Euros for further product innovation and growth

 

High Volume Sample Storage in Space Efficient 96-Well Format

 

Cherwell Publishes Guide on Sterility Testing

 

Effective Removal of DMSO from Stored Samples

 

ATL Webcast: A Practical Guide to Selecting the Right LIMS

 

Genetic study reveals how gut bacteria work to keep us healthy

 

Lonza Establishes Custom Cell Biology Services to Offer Unique Manufacturing and Testing Capabilities

 

Thermo Fisher Scientific Opens Food Safety Customer Solution Center in India

 

 


 

 


 

Can't find what you are looking for?

Search by company or by product


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd